Healthcare provider profile · identity verified

Michael Kinkade

Allopathic & Osteopathic Physicians|Family Medicine · COLUMBIA, MO · NPI 1588774889

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Michael Kinkade received $47.85 in general payments during 2025 across 2 reported records.

Dexcom, Inc. accounted for 61.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$47.85

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$29.53	61.7%	1	2025
Merck Sharp & Dohme LLC	Unresolved — no canonical attribution shown	$18.32	38.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$47.85	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$29.53	1	2025
Source payment records 2025-08-06 · Dexcom, Inc. · $29.53 · Open Payments source
CAPVAXIVE Normalized: capvaxive	Biological	Merck Sharp & Dohme LLC	$18.32	1	2025
Source payment records 2025-01-28 · Merck Sharp & Dohme LLC · $18.32 · Open Payments source
GARDASIL 9 Normalized: gardasil 9	Biological	Merck Sharp & Dohme LLC	$18.32	1	2025
Source payment records 2025-01-28 · Merck Sharp & Dohme LLC · $18.32 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	834	192
Atorvastatin Calcium	Atorvastatin Calcium	829	233
Omeprazole	Omeprazole	552	140
Lisinopril	Lisinopril	518	135
Amlodipine Besylate	Amlodipine Besylate	495	133
Gabapentin	Gabapentin	462	117
Montelukast Sodium	Montelukast Sodium	404	102
Metformin Hcl	Metformin Hcl	328	92
Tamsulosin Hcl	Tamsulosin Hcl	310	86
Losartan Potassium	Losartan Potassium	295	84
Rosuvastatin Calcium	Rosuvastatin Calcium	269	73
Alprazolam	Alprazolam	240	46
Duloxetine Hcl	Duloxetine Hcl	219	61
Hydrochlorothiazide	Hydrochlorothiazide	214	69
Pantoprazole Sodium	Pantoprazole Sodium	211	55
Albuterol Sulfate Hfa	Albuterol Sulfate	198	56
Allopurinol	Allopurinol	174	44
Potassium Chloride	Potassium Chloride	161	36
Trazodone Hcl	Trazodone Hcl	150	30
Sertraline Hcl	Sertraline Hcl	149	31
Finasteride	Finasteride	148	34
Furosemide	Furosemide	146	41
Carvedilol	Carvedilol	139	35
Fluticasone Propionate	Fluticasone Propionate	133	30
Eliquis	Apixaban	128	25
Simvastatin	Simvastatin	127	45
Metoprolol Succinate	Metoprolol Succinate	122	37
Tramadol Hcl	Tramadol Hcl	121	36
Famotidine	Famotidine	115	25
Ozempic	Semaglutide	115	21
Metformin Hcl Er	Metformin Hcl	114	34
Celecoxib	Celecoxib	108	26
Escitalopram Oxalate	Escitalopram Oxalate	105	20
Citalopram Hbr	Citalopram Hydrobromide	97	18
Metoprolol Tartrate	Metoprolol Tartrate	96	25
Donepezil Hcl	Donepezil Hcl	88	22
Zolpidem Tartrate	Zolpidem Tartrate	88	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	30
Pravastatin Sodium	Pravastatin Sodium	85	24
Clopidogrel	Clopidogrel Bisulfate	84	26
Memantine Hcl	Memantine Hcl	80	14
Amitriptyline Hcl	Amitriptyline Hcl	79	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	26
Glimepiride	Glimepiride	72	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	72	12
Ezetimibe	Ezetimibe	69	20
Lorazepam	Lorazepam	68	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	12
Clonazepam	Clonazepam	61	15
Jardiance	Empagliflozin	61	13
Pregabalin	Pregabalin	61	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	18
Atenolol	Atenolol	56	16
Doxazosin Mesylate	Doxazosin Mesylate	53	17
Paroxetine Hcl	Paroxetine Hcl	53	suppressed
Lovastatin	Lovastatin	52	14
Tizanidine Hcl	Tizanidine Hcl	50	17
Diclofenac Sodium	Diclofenac Sodium	49	18
Januvia	Sitagliptin Phosphate	49	12
Mounjaro	Tirzepatide	49	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	suppressed
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Meloxicam	Meloxicam	47	14
Glipizide	Glipizide	46	11
Benazepril Hcl	Benazepril Hcl	44	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	42	42
Spironolactone	Spironolactone	42	13
Torsemide	Torsemide	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	11
Methylprednisolone	Methylprednisolone	40	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Tradjenta	Linagliptin	39	11
Propranolol Hcl	Propranolol Hcl	38	suppressed
Synthroid	Levothyroxine Sodium	37	15
Baclofen	Baclofen	35	suppressed
Imipramine Hcl	Imipramine Hcl	35	suppressed
Lansoprazole	Lansoprazole	35	12
Alendronate Sodium	Alendronate Sodium	34	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Temazepam	Temazepam	33	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Mupirocin	Mupirocin	31	24
Memantine Hcl Er	Memantine Hcl	29	suppressed
Cefdinir	Cefdinir	28	28
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Prednisone	Prednisone	24	13
Doxycycline Hyclate	Doxycycline Hyclate	23	16
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Myrbetriq	Mirabegron	21	suppressed
Primidone	Primidone	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Trulicity	Dulaglutide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	16	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Topiramate	Topiramate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diazepam	Diazepam	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Valsartan	Valsartan	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Entacapone	Entacapone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Risperidone	Risperidone	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$47.85 · 2 records	Dexcom, Inc.	CAPVAXIVE, Dexcom G6 Transmitter, GARDASIL 9	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error